BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9051125)

  • 1. [Molecular diagnostic detection of circulating tumor cells and their prognostic implications].
    Nakanishi H; Tatematsu M
    Gan To Kagaku Ryoho; 1997 Feb; 24(3):257-65. PubMed ID: 9051125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase chain reaction in long-term clinically disease-free melanoma patients.
    Mellado B; Gutierrez L; Castel T; Colomer D; Fontanillas M; Castro J; Estapé J
    Clin Cancer Res; 1999 Jul; 5(7):1843-8. PubMed ID: 10430090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
    Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
    Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of micrometastases and circulating tumor cells in melanoma prostatic and breast carcinomas.
    Ghossein RA; Carusone L; Bhattacharya S
    In Vivo; 2000; 14(1):237-50. PubMed ID: 10757082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
    Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
    Tsao H; Nadiminti U; Sober AJ; Bigby M
    Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL; Dean RC; Pinto A; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
    J Urol; 1999 Apr; 161(4):1070-6. PubMed ID: 10081840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
    Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
    Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells.
    Burchill SA; Perebolte L; Johnston C; Top B; Selby P
    Br J Cancer; 2002 Jan; 86(1):102-9. PubMed ID: 11857020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
    Hoon DS; Bostick P; Kuo C; Okamoto T; Wang HJ; Elashoff R; Morton DL
    Cancer Res; 2000 Apr; 60(8):2253-7. PubMed ID: 10786692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour microdissemination and survival in metastatic melanoma.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Franzke A; Sel S; Atzpodien E; Buer J
    Anticancer Res; 2000; 20(5B):3619-24. PubMed ID: 11131671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
    Tessier MH; Denis MG; Lustenberger P; Dreno B
    Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Quaglino P; Osella-Abate S; Cappello N; Ortoncelli M; Nardò T; Fierro MT; Cavallo F; Savoia P; Bernengo MG
    Melanoma Res; 2007 Apr; 17(2):75-82. PubMed ID: 17496782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.